Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Gelesis, Inc.
Type
Private
Industry Healthcare, Biotechnology
Founded 2008
Headquarters Boston, Massachusetts
Key people
John LaMattina, PhD – Chairman, Yishai Zohar, PhD - CEO and Founder, Robert W. Armstrong, PhD – Chief Business Officer
Website http://www.gelesis.com/

Gelesis is a privately held biotechnology company located in Boston, Massachusetts. The company is developing orally administered medical devices made out of food ingredients that, when taken with water, expand in the stomach to give a feeling of satiety. The particles mix with food, keeping it in the stomach longer and slowing the absorption of nutrients in the small intestine. Gelesis' first investigational device, Gelesis100, is currently in proof of concept clinical studies for the treatment of obesity.

Investment goal date:
Dividends reinvested
Gelesis, Inc. GLSS report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks